Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Toxicol Appl Pharmacol ; 383: 114785, 2019 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-31629732

RESUMEN

Celastrol (CS), an active triterpene derived from traditional Chinese medicine Tripterygium wilfordii Hook. f, has been used to treat chronic inflammation, arthritis and other diseases. However, it has been reported that CS can trigger cardiotoxicity and the molecular mechanism of heart injury induced by CS is not clear. Considering the wide application of Tripterygium wilfordii Hook. f in clinics, it is necessary to develop an accurate and reliable method to assess the safety of CS, and to elucidate as much as possible the mechanism of cardiotoxicity induced by CS. In this study, Ultra-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (UPLC-Q-TOF/MS)-based metabolomics revealed clues to the mechanism of CS-induced heart injury. Palmitic acid significantly increased in plasma from CS-treated rats, and this increase resulted in oxidative stress response in vivo. Excessive ROS further activate TNF signaling pathway and caspase family, which were obtained from the KEGG enrichment analysis of network toxicology strategy. Protein expression level of caspase-3, caspase-8, bax were significantly increased by western blot. Q-PCR also showed the similar results as western blot. It means that apoptosis plays a key role in the process of celastrol induced cardiotoxicity. Blocking this signal axis may be a potential way to protect myocardial tissue.


Asunto(s)
Cardiotoxinas/toxicidad , Redes y Vías Metabólicas/efectos de los fármacos , Metabolómica/métodos , Tripterygium/toxicidad , Triterpenos/toxicidad , Animales , Cardiotoxicidad/metabolismo , Cardiotoxinas/metabolismo , Masculino , Redes y Vías Metabólicas/fisiología , Triterpenos Pentacíclicos , Ratas , Ratas Wistar , Tripterygium/metabolismo , Triterpenos/metabolismo
2.
J Cardiovasc Pharmacol ; 62(6): 549-58, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24084217

RESUMEN

Chronically elevated levels of endothelin-1 (ET-1) have been detected in several cardiovascular diseases. In this study, we investigated the chronic effects of ET-1 on the electrophysiological characteristics expected to influence the genesis and maintenance of ventricular arrhythmia (VA). Rabbits were randomized to ET-1 (ET-1 group) or 0.9% saline (control group) for 2 weeks. The S1-S2 protocol and S1-S1 dynamic pacing were performed to assess the action potential duration restitution (APDR) and to induce APD alternans or VA in 4 sites of Langendorff-perfused rabbit hearts. The beat-to-beat variability of repolarization was quantified as short-term variability and long-term variability. Compared with the control group, chronic ET-1 administration significantly prolonged QT intervals, APD at 90% repolarization (APD90), and effective refractory period (ERP), steepened the maximum slopes of the APDR curve, decreased the ERP/APD90 ratio, and increased the spatial dispersions of APD90, ERP, and maximum slopes (P < 0.05 for all). Moreover, chronic ET-1 administration markedly increased the short-term variability and long-term variability (P < 0.01 for all). APD alternans occurred in both groups, but the threshold of APD alternans was decreased at all sites in the ET-1 group (P < 0.01 for all). We also observed that chronic ET-1 stimulation significantly increased the incidence and duration of the VA episodes. These results suggest that chronic stimulation with ET-1 facilitated VA by steepening the APDR curve and increasing the spatial dispersion of APDR and beat-to-beat variability of repolarization.


Asunto(s)
Modelos Animales de Enfermedad , Endotelina-1/metabolismo , Ventrículos Cardíacos/metabolismo , Fibrilación Ventricular/metabolismo , Potenciales de Acción/efectos de los fármacos , Animales , Cardiotoxinas/administración & dosificación , Cardiotoxinas/metabolismo , Cardiotoxinas/farmacocinética , Cardiotoxinas/toxicidad , Técnicas Electrofisiológicas Cardíacas , Endotelina-1/administración & dosificación , Endotelina-1/farmacocinética , Endotelina-1/toxicidad , Frecuencia Cardíaca/efectos de los fármacos , Ventrículos Cardíacos/efectos de los fármacos , Ventrículos Cardíacos/inervación , Ventrículos Cardíacos/fisiopatología , Bombas de Infusión , Infusiones Intravenosas , Masculino , Perfusión , Conejos , Distribución Aleatoria , Periodo Refractario Electrofisiológico/efectos de los fármacos , Fibrilación Ventricular/inducido químicamente , Fibrilación Ventricular/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA